Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
South Korea
· Delayed Price · Currency is KRW 717.00
0.00 (0.00%)
At close: Dec 5, 2025
Kyung Nam Pharm Revenue
Kyung Nam Pharm had revenue of 13.09B KRW in the quarter ending March 31, 2025, a decrease of -26.03%. This brings the company's revenue in the last twelve months to 56.18B, down -9.99% year-over-year. In the year 2024, Kyung Nam Pharm had annual revenue of 60.79B with 2.51% growth.
Revenue (ttm)
56.18B
Revenue Growth
-9.99%
P/S Ratio
1.00
Revenue / Employee
231.21M
Employees
243
Market Cap
56.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60.79B | 1.49B | 2.51% |
| Dec 31, 2023 | 59.30B | 303.06M | 0.51% |
| Dec 31, 2022 | 59.00B | -5.62B | -8.70% |
| Dec 31, 2021 | 64.62B | -6.31B | -8.89% |
| Dec 31, 2020 | 70.93B | 26.13B | 58.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| Kia Corporation | 113.20T |
| HD Hyundai Heavy Industries | 16.39T |